HRP20080090T3 - Naprava za aferezu - Google Patents

Naprava za aferezu

Info

Publication number
HRP20080090T3
HRP20080090T3 HR20080090T HRP20080090T HRP20080090T3 HR P20080090 T3 HRP20080090 T3 HR P20080090T3 HR 20080090 T HR20080090 T HR 20080090T HR P20080090 T HRP20080090 T HR P20080090T HR P20080090 T3 HRP20080090 T3 HR P20080090T3
Authority
HR
Croatia
Prior art keywords
aphesis
solid carrier
amyloid
bloodstream
app
Prior art date
Application number
HR20080090T
Other languages
English (en)
Croatian (hr)
Inventor
Mattner Frank
Schmidt Walter
Original Assignee
Affiris Forschungs- Und Entwicklungs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20080090(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Affiris Forschungs- Und Entwicklungs Gmbh filed Critical Affiris Forschungs- Und Entwicklungs Gmbh
Publication of HRP20080090T3 publication Critical patent/HRP20080090T3/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
HR20080090T 2003-09-12 2004-09-13 Naprava za aferezu HRP20080090T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0144403A AT413336B (de) 2003-09-12 2003-09-12 Apherese-vorrichtung
PCT/AT2004/000311 WO2005025651A1 (de) 2003-09-12 2004-09-13 Apherese-vorrichtung

Publications (1)

Publication Number Publication Date
HRP20080090T3 true HRP20080090T3 (hr) 2008-03-31

Family

ID=34280361

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080090T HRP20080090T3 (hr) 2003-09-12 2004-09-13 Naprava za aferezu

Country Status (15)

Country Link
US (2) US7935252B2 (cg-RX-API-DMAC7.html)
EP (1) EP1663347B1 (cg-RX-API-DMAC7.html)
JP (1) JP4509113B2 (cg-RX-API-DMAC7.html)
CN (1) CN100556472C (cg-RX-API-DMAC7.html)
AT (2) AT413336B (cg-RX-API-DMAC7.html)
AU (1) AU2004271651B2 (cg-RX-API-DMAC7.html)
CA (1) CA2538305C (cg-RX-API-DMAC7.html)
CY (1) CY1107911T1 (cg-RX-API-DMAC7.html)
DE (1) DE502004005851D1 (cg-RX-API-DMAC7.html)
DK (1) DK1663347T3 (cg-RX-API-DMAC7.html)
ES (1) ES2298789T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080090T3 (cg-RX-API-DMAC7.html)
PL (1) PL1663347T3 (cg-RX-API-DMAC7.html)
PT (1) PT1663347E (cg-RX-API-DMAC7.html)
WO (1) WO2005025651A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003303198A1 (en) 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT500483B1 (de) * 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) * 2005-03-15 2006-10-15 Mattner Frank Dr Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) * 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
JP2011508622A (ja) * 2007-12-21 2011-03-17 ジーイー・ヘルスケア・バイオ−サイエンシズ・アーベー 化学的に活性化された固相支持体材料の滅菌のための方法
EP2320987A1 (en) * 2008-07-29 2011-05-18 Medtronic, Inc. Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) * 2008-12-19 2010-06-24 Baxter International Inc. Systems and methods for obtaining immunoglobulin from blood
CA2748561C (en) * 2008-12-22 2016-11-01 Kaneka Corporation A.beta. remover, a.beta. removing apparatus and a.beta. removal system
US20110033463A1 (en) * 2009-08-06 2011-02-10 Medtronic, Inc. Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) * 2011-03-07 2012-09-12 Charité - Universitätsmedizin Berlin Use of aptamers in therapy and/or diagnosis of autoimmune diseases
PT2579042E (pt) 2011-10-04 2014-09-09 Affiris Ag Método para detecção de anticorpos específicos para a numa amostra biológica.
US9717841B2 (en) 2012-09-11 2017-08-01 Gary L. McNeil Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
AU2015286606A1 (en) 2014-07-10 2017-01-12 Affiris Ag Substances and methods for the use in prevention and/or treatment in huntington's disease
CN107074925B (zh) 2014-07-10 2021-08-24 阿费里斯股份公司 用于预防和/或治疗亨廷顿氏病的物质和方法
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
GB201904810D0 (en) * 2019-04-05 2019-05-22 Cynapsedx Ltd The treatment of protein aggregation diseases
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57103649A (en) * 1980-12-18 1982-06-28 Asahi Chemical Ind Sterilized gamma-globulin fixing column
EP0236509B1 (en) 1985-09-19 1993-02-10 Toray Industries, Inc. B2-microglobulin-removing column
JPH01171638A (ja) * 1987-12-25 1989-07-06 Kanegafuchi Chem Ind Co Ltd 血清アミロイドａ蛋白用吸着体
DE3880647T2 (de) * 1987-11-20 1993-11-18 Kanegafuchi Chemical Ind Sorbentmittel für Serum-Amyloid-Proteine.
US5216127A (en) * 1987-11-20 1993-06-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Adsorbent for serum amyloid protein
US5604102A (en) * 1992-04-15 1997-02-18 Athena Neurosciences, Inc. Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja) 1992-09-21 1994-04-15 Matsushita Electric Ind Co Ltd ロータリートランス
AU691297B2 (en) * 1994-05-13 1998-05-14 Miltenyi Biotec Gmbh Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
DE19515554C2 (de) * 1995-04-27 1999-06-17 Braun Melsungen Ag Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US5868936A (en) * 1996-06-20 1999-02-09 Baxter International Inc. Affinity membrane system and method of using same
US6787523B1 (en) * 1997-12-02 2004-09-07 Neuralab Limited Prevention and treatment of amyloidogenic disease
DE1257584T1 (de) 2000-02-24 2003-05-28 Lilly Co Eli Humanisierte antikörper, die amyloid beta peptid demarkieren
TWI238251B (en) * 2000-07-13 2005-08-21 Anawrhta Biotech Co Ltd In-vitro adsorbing device using immunity
WO2003051374A2 (en) * 2001-12-17 2003-06-26 New York State Office Of Mental Health SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
AU2003303198A1 (en) * 2002-12-19 2004-07-14 New York University Method for treating amyloid disease
AT413945B (de) * 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
AT413946B (de) * 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) * 2004-09-13 2007-12-15 Affiris Forschungs & Entwicklungs Gmbh Cholinestertransport-protein-mimotop als atherosklerose-medikament

Also Published As

Publication number Publication date
AT413336B (de) 2006-02-15
ES2298789T3 (es) 2008-05-16
ATA14442003A (de) 2005-07-15
AU2004271651A1 (en) 2005-03-24
JP2007504863A (ja) 2007-03-08
CA2538305C (en) 2011-05-24
HK1096320A1 (zh) 2007-06-01
JP4509113B2 (ja) 2010-07-21
DK1663347T3 (da) 2008-05-19
PL1663347T3 (pl) 2008-06-30
CN100556472C (zh) 2009-11-04
ATE382383T1 (de) 2008-01-15
DE502004005851D1 (de) 2008-02-14
US20070026029A1 (en) 2007-02-01
EP1663347A1 (de) 2006-06-07
EP1663347B1 (de) 2008-01-02
CY1107911T1 (el) 2013-09-04
AU2004271651B2 (en) 2009-08-06
CN1867365A (zh) 2006-11-22
US20110166327A1 (en) 2011-07-07
CA2538305A1 (en) 2005-03-24
WO2005025651A1 (de) 2005-03-24
US7935252B2 (en) 2011-05-03
PT1663347E (pt) 2008-03-28

Similar Documents

Publication Publication Date Title
HRP20080090T3 (hr) Naprava za aferezu
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
HRP20080564T3 (hr) Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
TW200501454A (en) Light emitting devices (IIII)
ATE380576T1 (de) Parallelfluss-kontaktoren mit blattförmigen adsorbentmaterial
TW200503296A (en) Light emitting devices
IT1317727B1 (it) Sostanze che assorbono i raggi ultravioletti costituite dabenzotriazoli aventi una aumentata durata.
EP1575534A4 (en) D4.5 GLYCURONIDASE AND ITS USES
DK1601897T3 (da) Armatur
BR0304165B1 (pt) mancais laterais de contato constante e de altura reduzida.
DE50310977D1 (de) Kompaktiertes menthol
EA200600404A1 (ru) Пероральные препаративные формы кладрибина
EP1549106A4 (en) SPEAKER MEMBRANE AND LOUDSPEAKER USING THIS
ATE454112T1 (de) Brustprothese
NO20052422D0 (no) Stabiliserte, fast tilstand polypeptidpartikler.
ITMI20001419A0 (it) Copolimeri termoprocessbili del tfe.
NL1023109A1 (nl) Samenstel, frame en houder.
DE502004002686D1 (de) Kontaktsystem
CY1106200T1 (el) Αντισωματα εναντια σε κασπαση-8, παρασκευη και χρηση τους
IS7538A (is) Prógestagena skammta einingar.
ES1052998Y (es) Dispositivo de seguridad mediante disco de rotura con presion de tarado multiple.
윤석임 Circular Infinity in James Dicky's Poetry
DE502006008485D1 (de) Mobiles Endgerät mit Anwendungen abhängig von den Anordnungen zweier Gehäuseteilen
ATE308739T1 (de) Einfach modifizierbares druckmessgerät durch membranfederträger
ES1052135Y (es) Regulador de presion.